Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients
Open Access
- 1 December 1998
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 9 (12) , 1351-1353
- https://doi.org/10.1023/a:1008409601731
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Differential Incorporation of Ara-C, Gemcitabine, and Fludarabine Into Replicating and Repairing DNA in Proliferating Human Leukemia CellsBlood, 1997
- Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma.Journal of Clinical Oncology, 1997
- Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. ClassificationAnnals of Oncology, 1997
- Fludarabine- and gemcitabine-induced apoptosis: incorporation of analogs into DNA is a critical eventCancer Chemotherapy and Pharmacology, 1995
- A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]Blood, 1994
- Difluorodeoxycytidine (dFdC) — gemcitabine: A phase I studyInvestigational New Drugs, 1992
- A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.Journal of Clinical Oncology, 1991
- Activity of Fludarabine Monophosphate in Patients With Advanced Mycosis Fungoides: A Southwest Oncology Group StudyJNCI Journal of the National Cancer Institute, 1990
- Combined modality treatment of cutaneous T cell lymphoma: results of a 6-year follow-up.Journal of Clinical Oncology, 1986